Citius Pharmaceuticals, Inc. — Investor Relations & Filings
Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company that develops and commercializes critical care products. The company's diversified pipeline focuses on anti-infectives in adjunct cancer care, stem cell therapies, and prescription products. Its portfolio includes LYMPHIR™, an FDA-approved therapy for adult patients with relapsed or refractory cutaneous T-cell lymphoma (CTCL). Key product candidates in development include Mino-Lok®, an antibiotic lock solution intended to treat patients with catheter-related bloodstream infections, and Halo-Lido, a topical formulation for the treatment of hemorrhoids. Additionally, the company is advancing a stem cell therapy platform for conditions such as acute respiratory distress syndrome (ARDS).
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| CURRENT REPORT | 2026-06-01 | English | |
| REGISTRATION STATEMENT | 2026-05-22 | English | |
| CURRENT REPORT | 2026-05-15 | English | |
| QUARTERLY REPORT | 2026-05-15 | English | |
| 8-K - Citius Pharmaceuticals, Inc. (0001506251) (Filer) | 2026-04-24 | English | |
| 424B5 - Citius Pharmaceuticals, Inc. (0001506251) (Filer) | 2026-04-24 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47923554 | CURRENT REPORT | 2026-06-01 | English | ||
| 46860857 | REGISTRATION STATEMENT | 2026-05-22 | English | ||
| 46362590 | CURRENT REPORT | 2026-05-15 | English | ||
| 46363360 | QUARTERLY REPORT | 2026-05-15 | English | ||
| 36278647 | 8-K - Citius Pharmaceuticals, Inc. (0001506251) (Filer) | 2026-04-24 | English | ||
| 36137720 | 424B5 - Citius Pharmaceuticals, Inc. (0001506251) (Filer) | 2026-04-24 | English | ||
| 33641001 | 8-K - Citius Pharmaceuticals, Inc. (0001506251) (Filer) | 2026-04-06 | English | ||
| 33122239 | 8-K - Citius Pharmaceuticals, Inc. (0001506251) (Filer) | 2026-03-31 | English | ||
| 32892870 | 8-K - CITIUS PHARMACEUTICALS, INC. (0001506251) (Filer) | 2026-03-04 | English | ||
| 32892869 | ARS - CITIUS PHARMACEUTICALS, INC. (0001506251) (Filer) | 2026-02-24 | English | ||
| 32892871 | DEF 14A - CITIUS PHARMACEUTICALS, INC. (0001506251) (Filer) | 2026-02-24 | English | ||
| 30211696 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 30211698 | 10-Q Filing | 2026-02-13 | English | ||
| 30211695 | 8-K Filing | 2026-02-13 | English | ||
| 30211697 | 10-K/A Filing | 2026-01-28 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BIFIDO. Co. Ltd
Biotechnology firm developing human-derived Bifidobacterium…
|
238200 | KR | Manufacturing |
|
Binex Co., Ltd.
Biopharmaceutical firm with pharma manufacturing and biolog…
|
053030 | KR | Manufacturing |
|
BioAge Labs, Inc.
A clinical-stage biotech developing therapies for metabolic…
|
BIOA | US | Manufacturing |
|
Bioasis Technologies Inc.
Developing the xB3 platform to deliver therapeutics across …
|
BIOAF | CA | Manufacturing |
|
BioAtla, Inc.
Develops antibody-based therapeutics activated within the t…
|
BCAB | US | Manufacturing |
|
BIOBIJOU Co., Ltd.
Develops and manufactures medical aesthetic products like H…
|
489460 | KR | Manufacturing |
|
BioCardia, Inc.
Develops cell-derived therapeutics for cardiovascular and p…
|
BCDA | US | Manufacturing |
|
Biocartis Group NV
Develops and commercializes an automated molecular diagnost…
|
BCART | BE | Manufacturing |
|
Bioceltix S.A.
Develops stem cell-based medicinal products for veterinary …
|
BCX | PL | Manufacturing |
|
BioChem Pharma Inc.
Produces and commercializes high-quality pharmaceuticals, f…
|
— | CA | Manufacturing |
Citius Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34965/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34965 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34965 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34965 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34965}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Citius Pharmaceuticals, Inc. (id: 34965)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.